ID: ALA1161183

Max Phase: Preclinical

Molecular Formula: C6H16N2

Molecular Weight: 116.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)(CN)CCN

Standard InChI:  InChI=1S/C6H16N2/c1-6(2,5-8)3-4-7/h3-5,7-8H2,1-2H3

Standard InChI Key:  JJOABXBOTQOWCE-UHFFFAOYSA-N

Associated Targets(non-human)

Ornithine decarboxylase 167 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 116.21Molecular Weight (Monoisotopic): 116.1313AlogP: 0.32#Rotatable Bonds: 3
Polar Surface Area: 52.04Molecular Species: BASEHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.38CX LogP: -0.10CX LogD: -5.09
Aromatic Rings: 0Heavy Atoms: 8QED Weighted: 0.56Np Likeness Score: 0.53

References

1. Aizencang G, Frydman RB, Giorgieri S, Sambrotta L, Guerra L, Frydman B..  (1995)  Synthesis of isoornithines and methylputrescines. An evaluation of their inhibitory effects on ornithine decarboxylase.,  38  (21): [PMID:7473562] [10.1021/jm00021a024]

Source